Introduction: The infection with SARS-CoV-2 that affects the entire world has been shown to be more severe in patients with comorbidities The object of this study was to know the survival of renal transplant patients infected with this coronavirus Material and methods: Eligible were renal transplant patients with SARS-CoV-2 infection requiring hospitalization (moderate and severe degree) from the start of the pandemic to September 28, 2020 Survival analysis was performed with Kaplan-Meier tables in days, using statistical package SPSSw v25 Results: Data was collected for 66 patients from 4 renal transplant facilities;the mean age was 39 5 years (IQR 30 0-49 5);global survival was 59 10% Difference of 67 50% vs 46 15% was observed between receivers from living and dead donors respectively (without Log Rank significance of 0 068);70 25% survival in patients with low immunological risk and 44 82% for high risk (Log Rank 0 034) Conclusions: Comorbidities and immunosuppression greatly influence mortality in renal transplant patients immunological risk presents an important determinant of patient survival [ABSTRACT FROM AUTHOR] Copyright of Trends in Transplantation is the property of Publicidad Permanyer SLU and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission However, users may print, download, or email articles for individual use This abstract may be abridged No warranty is given about the accuracy of the copy Users should refer to the original published version of the material for the full abstract (Copyright applies to all Abstracts )
Survival of transplanted patients infected with moderate and severe COVID-19 in Mexico